Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-09-30

FDA Approved: TIMOPTIC — Supplemental Application (Bausch & Lomb Incorporated)

View source ↗

Summary

The FDA has approved a supplemental application for TIMOPTIC (timolol maleate) from Bausch & Lomb, indicating an approved change to the product’s labeling or in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TIMOPTIC (timolol maleate)

Snippet

SUPPL AP for TIMOPTIC (TIMOLOL MALEATE)